These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8733499)

  • 1. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.
    Gallon AM
    Thorax; 1996 Apr; 51(4):429-32. PubMed ID: 8733499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expectoration and inhalation therapy].
    Nakamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1421-5. PubMed ID: 2290225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolytics: when dispensable, when necessary?
    Dorow P
    Lung; 1990; 168 Suppl():622-6. PubMed ID: 2117172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis.
    Kellett F; Redfern J; Niven RM
    Respir Med; 2005 Jan; 99(1):27-31. PubMed ID: 15672845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis.
    App EM; Baran D; Dab I; Malfroot A; Coffiner M; Vanderbist F; King M
    Eur Respir J; 2002 Feb; 19(2):294-302. PubMed ID: 11866009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative investigation on sputum viscosity before and after administration of mistabron or physiological saline solution with and without physiotherapy (vibration-therapy) (author's transl)].
    Maesen F; Brombacher PJ; Buytendijk HJ; Janssen HC
    Acta Tuberc Pneumol Belg; 1974; 65(2):212-8. PubMed ID: 4371451
    [No Abstract]   [Full Text] [Related]  

  • 7. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised unblinded comparison of sputum viscosity for three methods of saline nebulisation in mechanically ventilated patients: A pilot study protocol.
    Arnott A; Hart R; McQueen S; Watson M; Sim M
    PLoS One; 2023; 18(8):e0290033. PubMed ID: 37590203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulised N-acetylcysteine used in acute tracheostoma obstruction.
    Patel A; Theokli C
    J Laryngol Otol; 2014 Dec; 128(12):1123-4. PubMed ID: 25274291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved sputum expectoration following a single dose of INS316 in patients with chronic bronchitis.
    Johnson FL; Donohue JF; Shaffer CL
    Chest; 2002 Dec; 122(6):2021-9. PubMed ID: 12475842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Nash EF; Stephenson A; Ratjen F; Tullis E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.
    Koppitz M; Eschenburg C; Salzmann E; Rosewich M; Schubert R; Zielen S
    PLoS One; 2016; 11(6):e0156999. PubMed ID: 27308826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis.
    Armstrong DS
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1412-3. PubMed ID: 14668253
    [No Abstract]   [Full Text] [Related]  

  • 14. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
    Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
    Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheological assessment of mucolytic agents on sputum of chronic bronchitics.
    Dippy JE; Davis SS
    Thorax; 1969 Nov; 24(6):707-13. PubMed ID: 5350721
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine.
    Hurst GA; Shaw PB; LeMaistre CA
    Am Rev Respir Dis; 1967 Nov; 96(5):962-70. PubMed ID: 6059205
    [No Abstract]   [Full Text] [Related]  

  • 18. THE IN VITRO REDUCTION IN VISCOSITY OF HUMAN TRACHEOBRONCHIAL SECRETIONS BY ACETYLCYSTEINE.
    SHEFFNER AL; MEDLER EM; JACOBS LW; SARETT HP
    Am Rev Respir Dis; 1964 Nov; 90():721-9. PubMed ID: 14211458
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological effects of N-acetyl-L-cysteine on the respiratory tract. (I). Quantitative and qualitative changes in respiratory tract fluid and sputum (author's transl)].
    Kogi K; Saito T; Kasé Y; Hitoshi T
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):569-78. PubMed ID: 7286849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.
    Sutton PP; Gemmell HG; Innes N; Davidson J; Smith FW; Legge JS; Friend JA
    Thorax; 1988 Jan; 43(1):57-60. PubMed ID: 3353875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.